Finally, understanding the full cadre of epoxyalcohols and other lipid products of eLOX3 enzymatic activity, and their specific roles in the mitigating metabolic disease, are of special pharmaceutical and clinical interest (15, 60–63). This evidence concerns the gene ALOXE3 and Other metabolic disease.